ALLANZ ARENA (SACH-CORP) invests in the Virtual Trading simulator. Take a look to the trader's performance in the trading game.
Learn to trade Stocks, Forex & Commodities without risks in Virtual Trading. You can also join Virtual Trading and start investing without risks!
09:17 (CEST) on 28 April 2015
Buy 6 shares of GLAXOSMITHKLINE at £1546.00 per share.
12:27 (CEST) on 29 April 2015
Sell 10 shares of ROLLS-ROYCE at £1042.00 per share.
12:51 (CEST) on 29 April 2015
Buy 2 shares of ASTRAZENECA at £4553.50 per share.
15:47 (CEST) on 29 April 2015
Buy 33 shares of Teva Pharmaceutical Industries at $61.14 per share.
21:53 (CEST) on 29 April 2015
Sell 21 shares of Activision Blizzard at $23.21 per share.
21:54 (CEST) on 29 April 2015
Sell 2 CFDs of US Tech 100 at $4483.62 per CFD.
12:43 (CEST) on 30 April 2015
Buy 1 share of MARKS&SPENCER at £557.00.
12:49 (CEST) on 30 April 2015
Buy 1 share of BAT TOBACCO at £3604.50.
12:52 (CEST) on 30 April 2015
Sell 5 shares of ROLLS-ROYCE at £1037.00 per share.
13:06 (CEST) on 30 April 2015
Sell 9 shares of GLAXOSMITHKLINE at £1504.00 per share.
13:12 (CEST) on 30 April 2015
Sell 1 share of ASTRAZENECA at £4453.00.
13:14 (CEST) on 30 April 2015
Sell 8 shares of GLAXOSMITHKLINE at £1504.00 per share.
16:19 (CEST) on 30 April 2015
Sell 2 shares of GLAXOSMITHKLINE at £1505.50 per share.
16:20 (CEST) on 30 April 2015
Sell 4 CFDs of US Tech 100 at $4447.15 per CFD.
16:21 (CEST) on 30 April 2015
Sell 1 share of BAT TOBACCO at £3583.50.
16:23 (CEST) on 30 April 2015
Buy 29 shares of ROLLS-ROYCE at £1042.00 per share.
16:26 (CEST) on 30 April 2015
Buy 10 shares of ROLLS-ROYCE at £1042.00 per share.
16:44 (CEST) on 30 April 2015
Sell 33 shares of Teva Pharmaceutical Industries at $60.96 per share.
SACH-CORP's Timeline (ALLANZ ARENA)
Performance
Initial Capital
£100000.00
Account Valuation
£266494.50
Available Capital
£132143.02
Balance
£132143.02
Used Margin
£0.00
Paid Commissions
£2437.97
Invested Capital
£134351.48
Portfolio
Loading interactive chart...
Followers
Friends
(followers and followings)